Comparative Studies of Biosimilar Medicinal Products by O. B. Talibov

Get full text

The severity and dynamics of changes in the serum concentration of biochemical markers of muscle tissue damage in an experienced ultramarathon runner after overcoming a distance of... by E. N. Bezuglov, M. S. Shoshorina, O. B. Talibov

Get full text

The assessment of the structure of anti-doping rules violation and the evaluation of anti-doping measures efficiency in Russian athletics during 2000–2020 by E. N. Bezuglov, O. B. Talibov, V. Y. Khaitin, A. M. Lazarev

Get full text

EFFICIENCY AND SAFETY OF CHEMOTHERAPY REGIMEN WITH SQ109 IN THOSE SUFFERING FROM MULTIPLE DRUG RESISTANT TUBERCULOSIS by S. E. Borisov, E. M. Bogorodskaya, G. V. Volchenkov, E. V. Kulchavenya, A. O. Maryandyshev, S. N. Skornyakov, O. B. Talibov, A. M. Tikhonov, I. A. Vasilyeva

Get full text

Fortelyzin® in comparison with Metalyse® for ST-elevated myocardial infarction: one-year results and clinical outcomes of a multicenter randomized study FRIDOM1 by V. A. Markov, D. V. Duplyakov, S. L. Konstantinov, G. V. Klein, S. B. Aksentev, D. Yu. Platonov, E. V. Vyshlov, E. A. Ponomarev, R. M. Rabinovich, E. L. Makarov, E. V. Kulibaba, D. S. Yunevich, O. V. Kritskaia, E. A. Baranov, O. B. Talibov, E. A. Gerasimets

Get full text

Advanced results of Fortelyzin® use in the FRIDOM1 study and real clinical practice by V. A. Markov, D. V. Duplyakov, S. L. Konstantinov, G. V. Klein, S. B. Aksentiev, D. Yu. Platonov, E. V. Vyshlov, Е. A. Ponomarev, R. M. Rabinovich, E. L. Makarov, E. V. Kulibaba, D. S. Yunevich, O. V. Kritskaya, E. A. Baranov, O. B. Talibov, V. A. Kutsenko, A. A. Orlovsky, N. L. Vyazova, A. G. Koledinsky, A. M. Semenov, M. P. Semenov, E. B. Yarovaya, T. M. Uskach, R. M. Shakhnovich, S. N. Tereshchenko, S. S. Markin

Get full text